フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
- Companies Expect to Close the Transaction on November 3, 2006 - CORONA, Calif. and FT. LAUDERDALE, Fla., Oct. 31 /PRNewswire-FirstCall/...
CORONA, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) today announced that it has certified to the Federal...
Andrx Corporation (Nasdaq:ADRX) ("Andrx" or the "Company") announced today that on September 12, 2006, it certified that each representation and...
Andrx Corporation (Nasdaq:ADRX) ("Andrx" or the "Company") today announced its financial results for the three and six months ended June 30, 2006...
Andrx Corporation (NASDAQ:ADRX) today announced that it plans to issue its 2006 second quarter financial results press release and file its Form...
Andrx Corporation (Nasdaq:ADRX) ("Andrx" or the "Company") today announced its financial results for the three months ended March 31, 2006 (the...
CORONA, Calif. and FORT LAUDERDALE, Fla., May 3 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) and Andrx Corporation...
Andrx Corporation (NASDAQ:ADRX) today announced that it plans to issue its 2006 first quarter financial results press release and file its Form...
Andrx Corporation (Nasdaq:ADRX) announced today that Takeda Global Research & Development Center Inc. filed a New Drug Application (NDA) for a...
Andrx Corporation (Nasdaq:ADRX) ("Andrx" or the "Company") today announced its financial results for the three months and year ended December 31...
Andrx Corporation (NASDAQ:ADRX) today announced that it plans to issue its 2005 fourth quarter and full year financial results press release and...
- Andrx's patented sustained-release drug delivery technologies and solid pipeline of difficult-to-replicate generic products to strengthen and...
Andrx Corporation (Nasdaq:ADRX) is scheduled to present on Tuesday, February 7, 2006, at 3:20 p.m. ET at the Merrill Lynch Global Pharmaceutical...
Andrx Corporation (Nasdaq:ADRX) ("Andrx" or the "Company") announced today that it has entered into an agreement with InvaGen Pharmaceuticals Inc...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約